Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on April 2, 2009

Arteriosclerosis, Thrombosis, and Vascular Biology. 2009
Published online before print April 2, 2009, doi: 10.1161/ATVBAHA.109.184739
A more recent version of this article appeared on June 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/6/816    most recent
ATVBAHA.109.184739v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, S.-H.
Right arrow Articles by Chen, Y.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, S.-H.
Right arrow Articles by Chen, Y.-L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Medline Plus Health Information
*Peripheral Arterial Disease

Submitted on March 19, 2008
Accepted on March 18, 2009

Late Outgrowth Endothelial Cells Derived From Wharton Jelly in Human Umbilical Cord Reduce Neointimal Formation After Vascular Injury. Involvement of Pigment Epithelium-Derived Factor

Shu-Huei Wang ; Shing-Jong Lin ; Yung-Hsiang Chen ; Fen-Yen Lin ; Jin-Chung Shih ; Chau-Chung Wu ; Hua-Lin Wu ; and Yuh-Lien Chen *

From the Department of Anatomy and Cell Biology (S.-H.W., Y.-L.C.), College of Medicine, the Department of Obstetrics & Gynecology (J.-C.S.), and the Department of Internal Medicine (C.-C.W.), National Taiwan University Hospital, Taipei; the Institute of Clinical Medicine (S.-J.L.), National Yang-Ming University; the Graduate Institute of Integrated Medicine (Y.-H.C.), College of Chinese Medicine, China Medical University, Taichung; the Department of Anesthesia (F.-Y.L.), School of Medicine, Taipei Medical University; and the Department of Biochemistry and Molecular Biology (H.-L.W.), College of Medicine, National Cheng-kung University, Tainan, Republic of China.

* To whom correspondence should be addressed. E-mail: ylchenv{at}ntu.edu.tw.

Objectives—The number of endothelial progenitor cells (EPCs) that can be obtained from adult bone marrow and peripheral blood to treat cardiovascular diseases is limited. The goal was to examine the endothelial potential of Wharton jelly in human umbilical cord (WJC)-derived stem cells and evaluate their potential to affect neointimal formation after vascular injury.

Methods and Results—Mesenchymal cells (MCs) were isolated from WJC and cultured in endothelial growth medium. Differentiation into late outgrowth endothelial cells (WJC-OECs) was demonstrated by incorporation of acetylated low-density lipoprotein and expression of the endothelial-specific markers. Transplantation of these cells into wire-injured femoral arteries in mice led to rapid reendothelialization. At 4 weeks after injury, the neointima/media area ratio was reduced and strong expression of pigment epithelium-derived factor (PEDF) compared to saline-or MC- or cord blood-OEC-treated mice. WJC-OECs–conditioned medium has an extremely strong capacity to inhibit the migration and proliferation of smooth muscle cells. The effects were inhibited by neutralizing antibody for PEDF and by siRNA silencing of PEDF.

Conclusions—We firstly demonstrated the presence of a cell population within WJC that has the potential to differentiate into OECs. Transplantation of WJC-OECs may play a crucial role in reestablishing endothelial integrity in injured vessels, thereby inhibiting neointimal hyperplasia. These findings have implications for a novel and practical cell-based therapy for vascular diseases.


Key words: endothelial progenitor cells • restenosis • Wharton jelly • cell therapy • pigment epithelium-derived factor